With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma  (https://www.myeloma.org/largest-study-to-evaluate-benefits-of-precursor-MGUS-screening-multiple-myeloma)